Growth Factor Antagonist For Organ Transplant Alloimmunity And Arteriosclerosis


The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth factor receptors and other receptors, to prevent, inhibit, or ameliorate allograft rejection or arteriosclerosis in organisms that receive an organ transplant.

CPC Classifications

Sign in to the Lens